Metapneumonia Virus A B detection and Differentiation RNA Detection Qualitative Test
At DNA Labs UAE, we offer the Metapneumonia Virus A B detection and Differentiation RNA Detection Qualitative Test. This test is designed to detect and differentiate between Metapneumonia Virus A and B.
Test Details
The Metapneumonia Virus A B detection and Differentiation RNA Detection Qualitative Test is a diagnostic tool that specifically targets the RNA (genetic material) of the virus. It is used to determine the presence of the virus and identify the specific strain. The test follows a qualitative approach, providing a simple “positive” or “negative” result.
If the test is positive, it indicates the presence of either Metapneumonia Virus A or B. However, further testing or analysis may be required to differentiate between the two strains.
The test is typically performed using a sample obtained from the respiratory tract, such as a nasopharyngeal swab or bronchoalveolar lavage fluid. The sample is then processed in our laboratory using molecular techniques like reverse transcription polymerase chain reaction (RT-PCR).
RT-PCR is a sensitive and specific method that allows the amplification and detection of viral RNA. In this test, the viral RNA is converted into complementary DNA (cDNA) using reverse transcription enzymes. The cDNA is then amplified using PCR, and the resulting products are analyzed to determine the presence or absence of Metapneumonia Virus A or B.
Test Components
- Price: 1870.0 AED
- Sample Condition: Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC.
- Report Delivery: 4th Working Day Email (48 hours) / On phone (36 hours)
- Method: Real Time PCR
- Test Type: Viral
- Doctor: Physician
- Test Department: Genetics
- Pre Test Information: Need to sign Consent document and bring any clinical history of patient for Metapneumonia Virus A, B detection and Differentiation (RNA Detection) Qualitative Test
Importance of the Test
The Metapneumonia Virus A B detection and Differentiation RNA Detection Qualitative Test is crucial for the diagnosis and management of respiratory infections caused by Metapneumonia Virus A and B. By accurately detecting and differentiating between the two strains, healthcare providers can make informed decisions regarding patient care, treatment, and infection control measures.
For more information about the test or to schedule an appointment, please contact DNA Labs UAE.
Test Name | Metapneumonia Virus A B detection and Differentiation RNA Detection Qualitative Test |
---|---|
Components | |
Price | 1870.0 AED |
Sample Condition | Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC. |
Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
Method | Real Time PCR |
Test type | Viral |
Doctor | Physician |
Test Department: | Genetics |
Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMetapneumonia Virus A, B detection and Differentiation (RNA Detection) QualitativeTest |
Test Details |
The Metapneumonia Virus A, B detection and differentiation (RNA detection) qualitative test is a diagnostic tool used to detect and differentiate between Metapneumonia Virus A and B. This test specifically targets the RNA (genetic material) of the virus to determine its presence and identify the specific strain. The test follows a qualitative approach, meaning it provides a simple “positive” or “negative” result. If the test is positive, it indicates the presence of either Metapneumonia Virus A or B. However, to differentiate between the two strains, further testing or analysis may be required. The test is typically performed using a sample obtained from the respiratory tract, such as a nasopharyngeal swab or bronchoalveolar lavage fluid. The sample is then processed in a laboratory using molecular techniques like reverse transcription polymerase chain reaction (RT-PCR). RT-PCR is a sensitive and specific method that allows the amplification and detection of viral RNA. In this test, the viral RNA is converted into complementary DNA (cDNA) using reverse transcription enzymes. The cDNA is then amplified using PCR, and the resulting products are analyzed to determine the presence or absence of Metapneumonia Virus A or B. This test is crucial for the diagnosis and management of respiratory infections caused by Metapneumonia Virus A and B. By accurately detecting and differentiating between the two strains, healthcare providers can make informed decisions regarding patient care, treatment, and infection control measures. |